NAFDAC To Continue Hydroxychloroquine Clinical Trial For COVID-19 Treatment Despite WHO’s Suspension Of Procedure

National Agency for Food and Drug Administration (NAFDAC) has declared that clinical trial of Hydroxychloroquine as a treatment of COVID-19 patients will continue in the country. This is in outright contradiction to World Health Organization (WHO) suspension of the use of the anti-malaria drug in solidarity trial for the treatment of COVID-19. WHO argued that the drug trial […]

The post NAFDAC To Continue Hydroxychloroquine Clinical Trial For COVID-19 Treatment Despite WHO’s Suspension Of Procedure appeared first on MojiDelano.Com.

Post a Comment

Thank You For Reading This Post......please drop your comment and don't forget you can also use Facebook comment and post them on facebook....share to your friends so they will also enjoy.... Thank You Once More.

Previous Post Next Post